Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Non Operating Investment Income (2016 - 2020)

Historic Non Operating Investment Income for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to -$10000.0.

  • Forte Biosciences' Non Operating Investment Income fell 12439.02% to -$10000.0 in Q1 2020 from the same period last year, while for Mar 2020 it was -$18000.0, marking a year-over-year decrease of 11428.57%. This contributed to the annual value of $33000.0 for FY2019, which is 20000.0% up from last year.
  • As of Q1 2020, Forte Biosciences' Non Operating Investment Income stood at -$10000.0, which was down 12439.02% from -$33000.0 recorded in Q4 2019.
  • Over the past 5 years, Forte Biosciences' Non Operating Investment Income peaked at $54000.0 during Q1 2016, and registered a low of -$74000.0 during Q1 2018.
  • Over the past 5 years, Forte Biosciences' median Non Operating Investment Income value was -$1000.0 (recorded in 2017), while the average stood at $3866.7.
  • The largest annual percentage gain for Forte Biosciences' Non Operating Investment Income in the last 5 years was 100000.0% (2018), contrasted with its biggest fall of 730000.0% (2018).
  • Quarter analysis of 5 years shows Forte Biosciences' Non Operating Investment Income stood at -$9000.0 in 2016, then plummeted by 244.44% to -$31000.0 in 2017, then surged by 200.0% to $31000.0 in 2018, then crashed by 206.45% to -$33000.0 in 2019, then soared by 69.7% to -$10000.0 in 2020.
  • Its last three reported values are -$10000.0 in Q1 2020, -$33000.0 for Q4 2019, and -$13000.0 during Q3 2019.